OC-0288 Long-term results of 15Gy HDRBT boost in intermediate risk-prostate cancer:Analysis of 500 + patients. - Mendez, L.; Martell, K.; Chung, H.; Tseng, C.; Alayed, Y.; Cheung, P.; Liu, S.; Vesprini, D.; Chu, W.; Szumacher, E.; Ravi, A.; Loblaw, A.; et al. (Radiotherapy & Oncology, 2019)